AD

Amritraj Debata

Active Director Director DIN 10645737
DIN 10645737 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Amritraj Debata

Data last updated:

Amritraj Debata is a Director at Malya Peak Tech Private Limited (since 2024) and Director at Vienox Medical Private Limited (since 2024).

DIN 10645737
Primary Designation Director
First Appointment 27 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Malya Peak Tech Private Limited U78300OD2024PTC047527
Director14 Dec 20242024Active
Vienox Medical Private Limited U32500OD2024PTC045961
Director27 May 20242024Active

Board colleagues of Amritraj Debata

Directorship timeline

Open interactive timeline →
Malya Peak Tech Private Limited
Vienox Medical Private Limited
Premium access

Shareholding and investment profile for Amritraj Debata

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amritraj Debata

Amritraj Debata currently holds 2 directorships: Malya Peak Tech Private Limited (Director, since 14 Dec 2024); Vienox Medical Private Limited (Director, since 27 May 2024).

Amritraj Debata was first appointed on 27 May 2024 as Director at Vienox Medical Private Limited.

The current boards of Amritraj Debata's companies include Bikash Singh Samal (Malya Peak Tech Private Limited), Rahul Batsya (Vienox Medical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available